The emerging advantages of positron-emission tomography (PET) myocardial perfusion imaging (MPI) for coronary artery disease (CAD) diagnosis and assessment of cardiovascular event risk has prompted ...
Chicago, Illinois (Embargoed until 2:15 p.m. CDT, Tuesday, June 27, 2023)—A novel PET perfusion radiotracer, 18 F-flurpiridaz, can diagnose coronary artery disease (CAD) in obese patients with a ...
A new radioactive tracer for positron emission tomography (PET) myocardial perfusion imaging will soon be available in the United States, and it’s expected to facilitate substantial growth in such ...
Researchers developed an AI model to detect myocardial ischemia and coronary microvascular and vasomotor dysfunction using ...
The study covered in this summary was published in medRxiv.org as a preprint and has not yet been peer-reviewed. In the first study to describe the magnitude of coronary microvascular collateral ...
A novel tracer for positron emission tomography (PET) myocardial perfusion imaging, called flurpiridaz F-18, performed well in a second phase III trial when it came to the detection of CAD in patients ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback